In order to reduce morbidity and mortality, guidelines for hypertension, coronary artery disease, and heart failure recommend treatment with beta-blockers and angiotensin-converting enzyme (ACE) inhibitors [1–3]. This evidence concerns the gene ACE and heart failure.